Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Women with PCOS have altered brain structure and reduced cognitive performance.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Baricitinib is effective and safe for treating severe alopecia areata.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

PCOS is common, affects hormones, and often diagnosed late, impacting women's quality of life.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Low testosterone levels may contribute to female pattern hair loss in men.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.